Article info
PDFSpecial populations
Original research
Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer
- Correspondence to Dr Kenneth Mangion, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, G12 8TA, UK; kenneth.mangion{at}glasgow.ac.uk
Citation
Cardiovascular sequelae of trastuzumab and anthracycline in long-term survivors of breast cancer
Publication history
- Received September 7, 2023
- Accepted November 13, 2023
- First published December 16, 2023.
Online issue publication
April 15, 2024
Article Versions
- Previous version (16 December 2023).
- Previous version (12 February 2024).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.